American Heart Association issues cautions on hormone replacement therapy for cardiovascular disease

July 23, 2001

DALLAS, July 24 - The American Heart Association today advised physicians against prescribing hormone replacement therapy (HRT) for the sole purpose of preventing heart attacks and strokes in women who already have cardiovascular disease, according to recommendations published in today's Circulation: Journal of the American Heart Association.

The new position is based on recent scientific studies about the role of HRT in reducing the risk of coronary heart disease in postmenopausal women.

For postmenopausal women who have had a heart attack or stroke, the guidelines recommend that HRT not be initiated for secondary prevention. This recommendation is based, in part, on the results of the Heart and Estrogen Replacement Study (HERS), a large-scale study that found no benefit of HRT among women with heart disease. For preventing a first heart attack or stroke, the association recommends reducing risk factors, such as high cholesterol and blood pressure, through lifestyle modifications and, if needed, with medications to improve cholesterol profiles and lower elevated blood pressure. Pending the results of ongoing studies, the guidelines recommend that the decision on HRT use be based primarily on non-heart related benefits and risks.

For those women with diagnosed cardiovascular disease, who are undergoing long term hormone replacement therapy, the decision to continue or stop HRT should be based on established noncoronary benefits and risks, as well as patient preference.

Because the data on HRT has been unclear, many physicians have asked the American Heart Association to clarify its position on HRT says Lori Mosca, M.D., Ph.D., lead author of the American Heart Association's Science Advisory, titled, "Hormone Replacement Therapy and Cardiovascular Disease." She is director of preventive cardiology at New York Presbyterian Hospital of Columbia and Cornell universities. "For many years, cardiologists and other health care providers who take care of women have assumed that HRT protects the heart," Mosca continues. "At this time there is not sufficient evidence to make that claim - our purpose is to clarify the role of hormones in heart disease prevention."

The statement concludes that for healthy women there is neither a compelling reason to initiate HRT for the sole purpose of primary coronary heart disease prevention, nor a compelling reason to discontinue it if she is doing well with therapy. For now, women and their physicians should shift their attention to lifestyle changes such as smoking cessation, weight loss and physical activity that are known to reduce the risk of cardiovascular diseases (CVD). Also, treatments like cholesterol-lowering drugs and blood pressure medication are proven to protect against CVD and are underutilized in women, she says. Cardiovascular diseases, which include heart attack and stroke, are the leading causes of death in women. After menopause, CVD risk rises sharply.

"For more than 50 million American women over age 50, the decision whether or not to use hormone replacement therapy is a difficult one. These guidelines should help physicians guide patients to the most effective therapies to lower an individual's risk of cardiovascular disease." According to Mosca, the established benefits of HRT for the treatment of menopausal symptoms, such as hot flashes, and the prevention of osteoporosis, must be weighed against risks for blood clots, gallbladder disease and a possible increased risk of breast cancer.

"The new guidelines recommend essentially taking HRT out of the risk-benefit equation for women who have already had a heart attack or stroke," Mosca says. "For postmenopausal women without heart disease, we do not suggest that HRT be taken completely out of the equation. We state that heart disease prevention should not be used as the sole purpose of therapy. It can weigh into the decision, it just shouldn't drive the decision for women without heart disease. "The prevailing wisdom for decades has been that hormones protect the heart," Mosca says. "This is based on quite reasonable assumptions. Compared to men, women have a delayed onset of heart disease by about 10 years. It has been assumed that this protection has been afforded to women because they have estrogen and men don't." In addition, epidemiological studies have indicated that HRT reduces heart attacks in healthy women. However, because women who are prescribed HRT are often healthier than those who are not, these studies cannot be considered definitive because women are not randomly assigned to treatment.

Two large, randomized studies of healthy women designed to avoid those biases - the Women's Health Initiative, sponsored by the National Heart, Lung and Blood Institute, and the WISDOM trial in Europe - are expected to report results in five to eight years. "Those studies will provide more definitive answers about HRT for prevention of heart disease in healthy women," says Mosca.
Co-authors include: Peter Collins, M.D.; David M. Herrington, M.D.; Michael E. Mendelsohn, M.D.; Richard C. Pasternak, M.D.; Rose Marie Robertson, M.D.; Karin Schenck-Gustafsson, M.D., Ph.D.; Sidney C. Smith, Jr., M.D.; Kathryn A. Taubert, Ph.D.; and Nanette K. Wenger, M.D.

CONTACT: For journal copies only,
please call: 214-706-1396
For other information, call:
Carole Bullock: 214-706-1279
Darcy Spitz: 212-878-5940

American Heart Association

Related Heart Disease Articles from Brightsurf:

Cellular pathway of genetic heart disease similar to neurodegenerative disease
Research on a genetic heart disease has uncovered a new and unexpected mechanism for heart failure.

Mechanism linking gum disease to heart disease, other inflammatory conditions discovered
The link between periodontal (gum) disease and other inflammatory conditions such as heart disease and diabetes has long been established, but the mechanism behind that association has, until now, remained a mystery.

New 'atlas' of human heart cells first step toward precision treatments for heart disease
Scientists have for the first time documented all of the different cell types and genes expressed in the healthy human heart, in research published in the journal Nature.

With a heavy heart: How men and women develop heart disease differently
A new study by researchers from McGill University has uncovered that minerals causing aortic heart valve blockage in men and women are different, a discovery that could change how heart disease is diagnosed and treated.

Heart-healthy diets are naturally low in dietary cholesterol and can help to reduce the risk of heart disease and stroke
Eating a heart-healthy dietary pattern rich in vegetables, fruits, whole grains, low-fat dairy products, poultry, fish, legumes, vegetable oils and nuts, which is also limits salt, red and processed meats, refined-carbohydrates and added sugars, is relatively low in dietary cholesterol and supports healthy levels of artery-clogging LDL cholesterol.

Pacemakers can improve heart function in patients with chemotherapy-induced heart disease
Research has shown that treating chemotherapy-induced cardiomyopathy with commercially available cardiac resynchronization therapy (CRT) delivered through a surgically implanted defibrillator or pacemaker can significantly improve patient outcomes.

Arsenic in drinking water may change heart structure raising risk of heart disease
Drinking water that is contaminated with arsenic may lead to thickening of the heart's main pumping chamber in young adults, according to a new study by researchers at Columbia University Mailman School of Public Health.

New health calculator can help predict heart disease risk, estimate heart age
A new online health calculator can help people determine their risk of heart disease, as well as their heart age, accounting for sociodemographic factors such as ethnicity, sense of belonging and education, as well as health status and lifestyle behaviors.

Wide variation in rate of death between VA hospitals for patients with heart disease, heart failure
Death rates for veterans with ischemic heart disease and chronic heart failure varied widely across the Veterans Affairs (VA) health care system from 2010 to 2014, which could suggest differences in the quality of cardiovascular health care provided by VA medical centers.

Heart failure: The Alzheimer's disease of the heart?
Similar to how protein clumps build up in the brain in people with some neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, protein clumps appear to accumulate in the diseased hearts of mice and people with heart failure, according to a team led by Johns Hopkins University researchers.

Read More: Heart Disease News and Heart Disease Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to